Mucins in assessment of tumoral biopotential
Abstract
The article presented the results of histological study of bioptates that were taken from different parts of gastrointestinal tract of 111 patients. The material was investigated after staining of the sections by means of histological methods that usually used for mucin selected revealing. The study demonstrated the histochemical and immunological marks of metaplasia transformation in dysplasia and adenocarcinoma for the esophagus, the stomach and the colon.
About the Authors
G. M. Mogilnaja
КубГМУ, ГБУЗ «Краевая клиническая больница № 2»
Russian Federation
Russian Federation
V. M. Durleshter
КубГМУ, ГБУЗ «Краевая клиническая больница № 2»
Russian Federation
Russian Federation
V. L. Mogilnaja
клиника «Екатерининская»
Russian Federation
Russian Federation
V. V. Ignatenko
КубГМУ, ГБУЗ «Краевая клиническая больница № 2»
Russian Federation
Russian Federation
References
1. Arnold C., Goel A., Blum H., Bocand R. Molecular pathogenesis of colorectal cancer // Cancer. - 2005. - V. 104. -P. 2035-2047.
2. Gao Li J., He X. et al. Histochemical studies on intestinal metaplasia adjacent to gastric cardia adenocarcinoma in subjects at ligh-incidence area in Henan, north China // World. j. gastroenterology. - 2005. - V. 11. - P. 4634-4637.
3. Hollingsworth M., Swanson B. Mucins in cancer: protection and control of the cell surface // Cancer. - 2004. - V. 4. - P. 45.
4. Hornick J., Odze R. Neoplastic precursor lesions in Barrett,s esophagus // Gastroenterol. clin. n. am. - 2007. - Vol. 36. -P. 775-796.
5. Lau S., Weiss L., Chu P. Differential expression of MUC 1, MUC 2 and MUC 5 AC in carcinomas of various sites // Am. j. clin. pathol. - 2004. - V. 122. - P. 61-69.
6. Lee S., Lee K., Kim S. et al. MUC 1, MUC 2 and MUC 5 AC and MUC 6 expressions in gastric carcinomas // Cancer. -2001. - V. 92. - P. 1427-1434.
7. Odze R. Diagnosis and grading of dysplasia in Barrett, soesophagus // J. clin. pathol. - 2006. - V. 59. -P. 1029-1038.
8. Pears A. Histochemistry. Teoretical and applied. -London,1968. - 561 p.
9. Sharma P., Marcon N., Wani S., Bansal A., Mathur S. et al. Non-biopsy detection of intestial metaplasia and displasia in Barrett,s esophagus: a prospective multicenter study // Endoscopy. - 2006. - V. 38. - P. 1206-1212.
10. Spechler S. intestinal metaplasia at the gastroesophageal junction // Gastroenterology. - 2004. - V. 126. - P. 567-575.
11. Srivastava G., Hornick J., Li X., Blount P., Sanchez C. et al. Extent of low-grade dysplasia is a risk factor for the development of oesophageal adenocarcinoma in Barrett,s esophagus // Am. j. gastroenterol. - 2007. - V. 102. - P. 483-493.
12. Wang K., Sampliner R. Practice parameters commitlee of the American college of gastroenterology. Up-dated quideline 2008 for the diagnosis, surveillance and therapy of Barrett's esophagus // Am. j. gastroenterology. - 2008. - V. 103. -P. 788-797.
13. Xiao-Dong Bu, Nan Li, Xiao-QiangTian et al. Altered expression of MUC 2 and MUC 5 AC in progression of colorectal carcinoma // World j. gastroenterology. 2010. - V. 16. -P. 4089-4094.
Review
For citations:
Mogilnaja G.M., Durleshter V.M., Mogilnaja V.L., Ignatenko V.V. Mucins in assessment of tumoral biopotential. Kuban Scientific Medical Bulletin. 2014;(4):88-92. (In Russ.)
Views:
236
Email this article 